The mammalian heart grows primarily by cell proliferation of cardiomyocyte prior to birth. Thereafter, the cardiomyocytes exit the cell cycle and their hypertrophy contributes to increase in myocardial volume. In the recent reports, several candidates of cardiac stem cells have been described in the mammalian adult heart. However, their lineage origin and function remain largely unknown. Among molecular markers for cardiac stem cells, islet-1 has been used to identify a cardiac progenitor cells in various model animals. In mammalian adult heart, islet-1-expressing (islet-1+) cells have been reported to be quiescent and not proliferative. Here, in order to examine a role of islet-1+ cells in Xenopus heart formation, we studied on the behavior of islet-1+ cells in the developing heart from metamorphosing larval stage to adulthood. RT-PCR analysis showed that islet-1 expression in ventricle increased during metamorphosis, and thereafter decreased in froglet heart. In immunostaining analysis, islet-1+ cells were widely detected within the ventricular muscles during metamorphosis, whereas islet-1+cells were found on the cardiomyocytes in the sexually matured adult heart. BrdU incorporation analysis indicated that cell proliferation occurs within ventricular muscles at high level during the climax of metamorphosis, and rapidly decreased after metamorphosis. Immunostaining analyses using anti-islet-1, anti-BrdU and antitropomyosin antibodies revealed that islet-1 + cells in Xenopus adult ventricle have ability to differentiate into cardiomyocyte through cell proliferation. Taken together, these results suggest that islet-1 + cells play a role in myocardial formation of adult heart in Xenopus laevis. Regulation of tube size is critical for luminal capacity, and misregulation is associated with congenital stenotic diseases. The mechanisms underlying tubulogenesis have been derived mainly from studies of aspects of epithelial cell biology, such as epithelial cell polarity, cytoskeleton and differences in cell adhesiveness, that are conserved across common model organisms. While organogenesis progresses by epithelial-mesenchymal interactions, the details of how tubulogenesis is regulated by surrounding mesenchymal cells remain largely unknown. Here, we focused on the trachea, the tubular uppermost region of the airway and an exclusive air passage for the delivery of inhalation flow.
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We carried out comprehensive quantitative analyses at scales ranging from single-cell to whole-organ throughout murine tracheal tubulogenesis, and determined that tracheal tubulogenesis is a stepwise process that involves a switch from tube elongation to expansion at E14.5. Furthermore, while tube expansion after E14.5, luminal epithelium underwent dynamic cell rearrangement process including 'apical enlargement' and 'apical emergence' to expand luminal surface area in addition to modest cell proliferation. Our genetic and mechanistic analyses show that mesenchymal Wnt5a-Ror2 signaling orchestrates mesenchymal cell polarity, and myosin phosphorylation in smooth muscle (SM) cells, which is crucial for SM architecture and contractility. Physiological contraction of SM may constrain the tracheal tube to elongate in the antero-posterior direction. We further reveal that proper cartilage development after E14.5 shifts the growth manner from tube elongation to tube expansion and forces passive epithelial cell rearrangements that shape the flat and vast luminal surface. We propose that the stepwise acquisition of oriented mesenchymal cells plays an important role in tracheal tubulogenesis. At the late developmental stage, the cells acquire mature physiological functions in exchange for their highly proliferative ability and differentiation potential. This tissue maturation makes the organs ready for birth. However, the precise timing and comprehensive mechanism of this dynamic process are still unknown.
To elucidate the spatiotemporal orchestration of this tissue maturation, we examined mouse developing trachea as a model. First we analyzed epithelial differentiation and proliferation pattern throughout trachea development. Immunostaining for the epithelial cell markers revealed sequential differentiation of three major epithelial cell types; basal, ciliated, and club cells, after E14.5. For example, basal cells, which work as the progenitor cells in adult, come to express Krt5 from E15.0. On the other hand, BrdU assay unveiled that the proliferation rate of epithelial cells was drastically decreased from 60% to 20% during E14.5 to E16.5. Therefore, we hypothesized that E14.5 is the key time point for beginning tissue maturation in which cell proliferation was diminished coincidently with cell differentiation.
To find out the determinant for tissue maturation, next we conducted Microarray analysis of tracheal epithelial cells from three time points at E14.5, E15.5, and E16.5. As expected, genes associated with cell cycles and DNA synthesis were decreased while CDK inhibitors such as p21 was increased. The time-course data analysis identified three factors (p73, FOXM1, and YAP) as candidate regulators of cell cycles. Now we are trying to find out the common upstream regulator for these factors (master regulator of tracheal tissue maturation) by using IPA (Ingenuity Pathways Analysis). Our final aim in the present study is to elucidate the spatiotemporal orchestration of the tracheal tissue maturation by revealing the signalling pathways that are commonly involved in tracheal epithelial cell proliferation and differentiation. doi:10.1016/j.mod.2017.04.421
Abstracts S149
